Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Teladoc Health Inc

Start price
Target price
Perf. (%)
€240.00
25.01.21
€350.00
25.01.22
-73.33%
26.01.22

Could be very worthwhile Investment >20% year
buy
Visiomed Group

Start price
Target price
Perf. (%)
€0.86
25.01.21
€1.00
25.01.22
-80.01%
24.01.22

Could be worthwhile Investment >10% per year
buy
Biosynex

Start price
Target price
Perf. (%)
€21.20
25.01.21
€26.00
25.01.22
-26.13%
20.10.21

Could be worthwhile Investment >10% per year
buy
Atossa Genetics Inc

Start price
Target price
Perf. (%)
€2.10
25.01.21
€3.00
25.01.22
63.56%
08.02.21

Could be worthwhile Investment >10% per year
buy
InVivo Therapeutics Holdings

Start price
Target price
Perf. (%)
€36.75
25.01.21
€50.00
25.01.22
-12.24%
08.02.21

Could be worthwhile Investment >10% per year
buy
Nuwellis Inc.

Start price
Target price
Perf. (%)
€7.55
25.01.21
€10.00
25.01.22
-2.65%
08.02.21

Could be very worthwhile Investment >20% year
buy
Atossa Genetics Inc

Start price
Target price
Perf. (%)
€1.85
23.01.21
€60.00
23.01.22
-41.51%
24.01.22

Could be very worthwhile Investment >20% year
buy
Star Equity Holdings Inc.

Start price
Target price
Perf. (%)
€3.16
23.01.21
€30.00
23.01.22
-67.09%
24.01.22

Could be very worthwhile Investment >20% year
buy
InVivo Therapeutics Holdings

Start price
Target price
Perf. (%)
€35.75
23.01.21
-
23.01.22
-73.67%
24.01.22

Could be very worthwhile Investment >20% year
buy
Drägerwerk AG & Co. KGaA ST

Start price
Target price
Perf. (%)
€67.80
23.01.21
€88.00
23.01.22
-26.99%
24.01.22

Fair valuation
Top 10 in its market
Future proof or reliable business model
Could be worthwhile Investment >10% per year
buy
Drägerwerk AG & Co. KGaA VZO

Start price
Target price
Perf. (%)
€71.80
23.01.21
€88.00
23.01.22
-30.36%
24.01.22

Market Leader or Top 3
Well known brand
Very Future proof/growth oriented business model
Revenue growth > 30% per year expected
buy
Intuitive Surgical Inc

Start price
Target price
Perf. (%)
€219.23
21.01.21
€215.00
2.46%
15.02.21

Known brand
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
buy
Crossject S.A.

Start price
Target price
Perf. (%)
€3.67
21.01.21
€10.00
21.01.22
-28.61%
22.01.22

Could be very worthwhile Investment >20% year
buy
Biocept Inc.

Start price
Target price
Perf. (%)
€147.00
21.01.21
€3,000.0
21.01.22
-48.16%
22.01.22

Could be very worthwhile Investment >20% year
buy
Drägerwerk AG & Co. KGaA VZO

Start price
Target price
Perf. (%)
€69.30
21.01.21
-
21.01.22
17.39%
29.06.21

buy
Fresenius SE & Co. KGaA

Start price
Target price
Perf. (%)
€39.13
11.01.21
€50.00
11.01.22
-5.37%
29.01.21

Could be worthwhile Investment >10% per year
Fair valuation
High dividend yield expected
Small challenges to pay loans and raise capital
buy
Asensus Surgical Inc.

Start price
Target price
Perf. (%)
€1.72
11.01.21
-
11.01.22
40.70%
19.01.21

Capable Management
Good culture
Dependend from some customers or products
buy
Nuwellis Inc.

Start price
Target price
Perf. (%)
€6.40
11.01.21
€8.00
17.97%
25.01.21

Could be very worthwhile Investment >20% year
buy
Atossa Genetics Inc

Start price
Target price
Perf. (%)
€0.79
11.01.21
€2.00
11.01.22
166.14%
25.01.21

Could be worthwhile Investment >10% per year
buy
InVivo Therapeutics Holdings

Start price
Target price
Perf. (%)
€22.25
11.01.21
€75.00
11.01.22
65.17%
25.01.21

Could be worthwhile Investment >10% per year
buy
Mediclin AG

Start price
Target price
Perf. (%)
€4.36
10.01.21
€6.00
10.01.22
-15.14%
11.01.22

EBIT growth >5% per year expected
positive Cash Flow expected
Top 10 in its market
Future proof or reliable business model
buy
Medtronic plc

Start price
Target price
Perf. (%)
€97.71
10.01.21
-
10.01.22
-2.05%
11.01.22

Could be worthwhile Investment >10% per year
Future proof or reliable business model
Known brand
buy
Fresenius SE & Co. KGaA

Start price
Target price
Perf. (%)
€39.22
04.01.21
€75.00
04.01.22
11.33%
05.09.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Higher EBIT margin than peer group
buy
Sonic Healthcare

Start price
Target price
Perf. (%)
€20.80
31.12.20
€46.00
31.12.21
45.65%
01.01.22

Revenue growth > 30% per year expected
Rising EBIT margin expected
Undervalued
High Investments for future growth
buy
Hologic Inc.

Start price
Target price
Perf. (%)
€60.00
31.12.20
€78.00
31.12.21
10.17%
01.01.22

Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Rising EBIT margin expected